Pronociceptive pain modulation in patients with painful chemotherapy-induced polyneuropathy

Journal of Pain and Symptom Management

Volumn 42, Issue 2, 2011, Pages 229-238

  Nahman Averbuch, Hadas ^a,b   Yarnitsky, David ^a,b   Granovsky, Yelena ^a,b   Sprecher, Elliot ^a   Steiner, Mariana ^c   Tzuk Shina, Tzahala ^b   Pud, Dorit ^a,d  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b RAMBAM MEDICAL CENTER   (Israel)

^c Lin Medical Center   (Israel)

^d UNIVERSITY OF HAIFA   (Israel)

Author keywords

Chemotherapy induced neuropathy; neuropathic pain; pain modulation

Indexed keywords

ANASTROZOLE; CARBOPLATIN; CISPLATIN; DULOXETINE; MEPROBAMATE; METHADONE; OXALIPLATIN; PACLITAXEL; PARACETAMOL; PREGABALIN; VINCRISTINE;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CHEMOTHERAPY INDUCED POLYNEUROPATHY; CLINICAL ARTICLE; COLD SENSITIVITY; CONDITIONED PAIN MODULATION; DRUG INDUCED DISEASE; FEMALE; HEAT SENSITIVITY; HUMAN; MALE; MECHANICAL STIMULATION; NEUROPATHIC PAIN; NOCICEPTION; PAIN ASSESSMENT; PAIN PARAMETERS; PAIN RECEPTOR; PAIN THRESHOLD; POLYNEUROPATHY; STIMULUS RESPONSE; TEMPORAL SUMMATION;

AGED; ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; NEURALGIA; PAIN MEASUREMENT; PAIN PERCEPTION; PAIN THRESHOLD; PHYSICAL STIMULATION; POLYNEUROPATHIES;

EID: 79960989604     PISSN: 08853924     EISSN: 18736513     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2010.10.268     Document Type: Article

References (50)

1. Haim N, Epelbaum R, Ben-Shahar M, et al. Full dose vincristine (without 2-mg dose limit) in the treatment of lymphomas. Cancer 1994;73:2515-2519. (Pubitemid 24155527)
2. Windebank AJ, Grisold W. Chemotherapyinduced neuropathy. J Peripher Nerv Syst 2008;13:27-46.
3. Flatters SJL, Bennett GJ. Ethosuximide reverses paclitaxel- and vincristine-induced painful peripheral neuropathy. Pain 2004;109:150-161. (Pubitemid 38479781)
4. Ocean AJ, Vahdat LT. Chemotherapy-induced peripheral neuropathy: pathogenesis and emerging therapies. Support Care Cancer 2004;12:619-625. (Pubitemid 39280311)
5. Cata JP, Weng HR, Lee BN, Reuben JM, Dougherty PM. Clinical and experimental findings in humans and animals with chemotherapyinduced peripheral neuropathy. Minerva Anestesiol 2006;72:151-169.
6. Siegal T, Haim N. Cisplatin-induced peripheral neuropathy. Frequent off-therapy deterioration, demyelinating syndromes, and muscle cramps. Cancer 1990;66:1117-1123.
7. Windebank AJ. Chemotherapeutic neuropathy. Curr Opin Neurol 1999;12:565-571. (Pubitemid 30028616)
8. Krishnan AV, Goldstein D, Friedlander M, Kiernan MC. Oxaliplatin-induced neurotoxicity and the development of neuropathy. Muscle Nerve 2005;32:51-60. (Pubitemid 40917889)
9. Cavaletti G, Beronio A, Reni L, et al. Thalidomide sensory neurotoxicity: a clinical and neurophysiologic study. Neurology 2004;62:2291-2293. (Pubitemid 38787791)
10. Plasmati R, Pastorelli F, Cavo M, et al. Neuropathy in multiple myeloma treated with thalidomide: a prospective study. Neurology 2007;69:573-581. (Pubitemid 47357264)
11. Hansen SW, Helweg-Larsen S, Trojaborg W. Long-term neurotoxicity in patients treated with cisplatin, vinblastine, and bleomycin for metastatic germ cell cancer. J Clin Oncol 1989;7:1457-1461. (Pubitemid 19245115)
12. Lipton RB, Galer BS, Dutcher JP, et al. Large and small fiber type sensory dysfunction in patients with cancer. J Neurol Neurosurg Psychiatry 1991;54:706-709.
13. Forsyth PA, Balmaceda C, Peterson K, et al. Prospective study of paclitaxel-induced peripheral neuropathy with quantitative sensory testing. J Neurooncol 1997;35:47-53. (Pubitemid 27361845)
14. Verstappen CC, Koeppen S, Heimans JJ, et al. Dose-related vincristine-induced peripheral neuropathy with unexpected off-therapy worsening. Neurology 2005;64:1076-1077. (Pubitemid 40388469)
15. Krarup-Hansen A, Helweg-Larsen S, Schmalbruch H, Rørth M, Krarup C. Neuronal involvement in cisplatin neuropathy: prospective clinical and neurophysiological studies. Brain 2007;130:1076-1088. (Pubitemid 47355585)
16. Attal N, Bouhassira D, Gautron M, et al. Thermal hyperalgesia as a marker of oxaliplatin neurotoxicity: a prospective quantified sensory assessment study. Pain 2009;144:245-252.
17. Cata JP,Weng HR, Burton AW, et al. Quantitative sensory findings in patients with bortezomib-induced pain. J Pain 2007;8:296-306. (Pubitemid 46551871)
18. Dougherty PM, Cata JP, Burton AW, Vu K, Weng HR. Dysfunction in multiple primary afferent fiber subtypes revealed by quantitative sensory testing in patients with chronic vincristine-induced pain. J Pain Symptom Manage 2007;33:166-179. (Pubitemid 46186866)
19. Dougherty PM, Cata JP, Cordella JV, Burton A, Weng HR. Taxol-induced sensory disturbance is characterized by preferential impairment of myelinated fiber function in cancer patients. Pain 2004;109:132-142. (Pubitemid 38479779)
20. Binder A, Stengel M, Maag R, et al. Pain in oxaliplatin-induced neuropathy - sensitization in the peripheral and central nociceptive system. Eur J Cancer 2007;43:2658-2663. (Pubitemid 350151837)
21. Veves A, Young MJ, Manes C, Boulton AJ. Differences in peripheral and autonomic nerve function measurements in painful and painless neuropathy. Diabetes Care 1994;17:1200-1202. (Pubitemid 24307459)
22. Bouhassira D, Attal N, Willer JC, Brasseur L. Painful and painless peripheral sensory neuropathies due to HIV infection: a comparison using quantitative sensory evaluation. Pain 1999;80:265-272. (Pubitemid 29151711)
23. Krämer HH, Rolke R, Bickel A, Birklein F. Thermal thresholds predict painfulness of diabetic neuropathies. Diabetes Care 2004;27:2386-2391. (Pubitemid 39281390)
24. Sorensen L, Molyneaux L, Yue DK. The relationship among pain, sensory loss, and small nerve fibers in diabetes. Diabetes Care 2006;29:883-887. (Pubitemid 44115311)
25. Martin C, Solders G, Sönnerborg A, Hansson P. Painful and non-painful neuropathy in HIV-infected patients: an analysis of somatosensory nerve function. Eur J Pain 2003;7:23-31. (Pubitemid 36149692)
26. Sorensen L, Molyneaux L, Yue DK. The level of small nerve fiber dysfunction does not predict pain in diabetic Neuropathy: a study using quantitative sensory testing. Clin J Pain 2006;22:261-265. (Pubitemid 44378548)
27. Yarnitsky D, Arendt-Nielsen L, Bouhassira D, et al. Conditioned Pain Modulation (CPM): recommendations on terminology and practice of psychophysical DNIC testing. Eur J Pain 2010;14:339.
28. Krause SJ, Backonja MM. Development of a neuropathic pain questionnaire. Clin J Pain 2003;19:306-314. (Pubitemid 37075671)
29. Granot M, Granovsky Y, Sprecher E, Nir RR, Yarnitsky D. Contact heat-evoked temporal summation: tonic versus repetitive-phasic stimulation. Pain 2006;122:295-305. (Pubitemid 43729473)
30. Maixner W, Fillingim R, Booker D, Sigurdsson A. Sensitivity of patients with painful temporomandibular disorders to experimentally evoked pain. Pain 1995;63:341-351.
31. Maixner W, Fillingim R, Sigurdsson A, Kincaid S, Silva S. Sensitivity of patients with painful temporomandibular disorders to experimentally evoked pain: evidence for altered temporal summation of pain. Pain 1998;76:71-81. (Pubitemid 28304943)
32. Bragdon EE, Light KC, Costello NL, et al. Group differences in pain modulation: pain-free women compared to pain-free men and to women with TMD. Pain 2002;96:227-237. (Pubitemid 34327868)
33. King CD, Wong F, Currie T, et al. Deficiency in endogenous modulation of prolonged heat pain in patients with Irritable Bowel Syndrome and Temporomandibular Disorder. Pain 2009;143:172-178.
34. Wilder-Smith CH, Schindler D, Lovblad K, Redmond SM, Nirkko A. Brain functional magnetic resonance imaging of rectal pain and activation of endogenous inhibitory mechanisms in irritable bowel syndrome patient subgroups and healthy controls. Gut 2004;53:1595-1601. (Pubitemid 39434102)
35. Wilder-Smith CH, Robert-Yap J. Abnormal endogenous pain modulation and somatic and visceral hypersensitivity in female patients with irritable bowel syndrome. World J Gastroenterol 2007;13:3699-3704. (Pubitemid 47202168)
36. Kosek E, Hansson P. Modulatory influence on somatosensory perception from vibration and heterotopic noxious conditioning stimulation (HNCS) in fibromyalgia patients and healthy subjects. Pain 1997;70:41-51. (Pubitemid 27128296)
37. Lautenbacher S, Rollman GB. Possible deficiencies of pain modulation in fibromyalgia. Clin J Pain 1997;13:189-196. (Pubitemid 27524077)
38. Staud R, RobinsonME, VierckCJ Jr, PriceDD. Diffuse noxious inhibitory controls (DNIC) attenuate temporal summation of second pain in normal males but not in normal females or fibromyalgia patients. Pain 2003;101:167-174.
39. Pielsticker A,Haag G, ZaudigM, Lautenbacher S. Impairment of pain inhibition in chronic tension-type headache. Pain 2005;118:215-223.
40. Witting N, Svensson P, Jensen TS. Differential recruitment of endogenous pain inhibitory systems in neuropathic pain patients. Pain 2003;103:75-81. (Pubitemid 36579087)
41. Tuveson B, Leffler AS, Hansson P. Heterotopic noxious conditioning stimulation (HNCS) reduced the intensity of spontaneous pain, but not of allodynia in painful peripheral neuropathy. Eur J Pain 2007;11:452-462. (Pubitemid 46366771)
42. Love-Jones SJ, Besson M, Steeds CE, et al. Homotopic stimulation can reduce the area of allodynia in patients with neuropathic pain. Eur J Pain 2009;13:942-948.
43. Bouhassira D, Danziger N, Attal N, Guirimand F. Comparison of the pain suppressive effects of clinical and experimental painful conditioning stimuli. Brain 2003;126:1068-1078. (Pubitemid 36522950)
44. Navarro X, Kennedy WR, Fries TJ. Small nerve fiber dysfunction in diabetic neuropathy. Muscle nerve 1989;12:498-507. (Pubitemid 19147512)
45. Navarro X, Kennedy WR. Evaluation of thermal and pain sensitivity in type I diabetic patients. J Neurol Neurosurg Psychiatry 1991;54:60-64.
46. Hilz MJ, Claus D, Neundörfer B, Zimmermann P, Berić A. Is heat hypoalgesia a useful parameter in quantitative thermal testing of alcoholic polyneuropathy? Muscle Nerve 1994;17:1456-1460.
47. Melzack R, Wall PD. Pain mechanisms: a new theory. Science 1965;150:971-979.
48. Wahren LK, Torebjörk E, Jörum E. Central suppression of cold-induced C fibre pain by myelinated fibre input. Pain 1989;38:313-319. (Pubitemid 19251254)
49. Yarnitsky D, Ochoa JL. Release of cold-induced burning pain by block of cold-specific afferent input. Brain 1990;113:893-902. (Pubitemid 20267464)
50. Yarnitsky D, Crispel Y, Eisenberg E, et al. Prediction of chronic post-operative pain: pre-operative DNIC testing identifies patients at risk. Pain 2008;138:22-28.